Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-Year follow-up, phase II Southwest Oncology Group study 9109

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 2016-2019

  Powell, Isaac J ^a   Tangen, Catherine M ^a   Miller, Gary J ^a   Lowe, Bruce A ^a   Haas, Gabriel ^a   Carroll, Peter R ^a   Osswald, Michael B ^a   Vere White, Ralph ^a   Thompson Jr , Ian M ^a   Crawford, E David ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Neoadjuvant therapy; Prostatectomy; Prostatic neoplasms

Indexed keywords

ANDROGEN; FLUTAMIDE; GOSERELIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEASIBILITY STUDY; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT FAILURE;

EID: 0036837254     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64285-1     Document Type: Article

References (11)

1. Vallett, B. S.: Radical perineal prostatectomy subsequent to bilateral orchiectomy. Delaware Med J, 16: 19, 1944
2. Colston, J. H. and Brendler, H.: Endocrine therapy in carcinoma of the prostate; preparation of patients for radical perineal prostatectomy. JAMA, 134: 848, 1947
3. Parlow, A. L. and Scott, W. W.: Hormone control therapy as a preparation for radical perineal prostatectomy in advanced carcinoma of the prostate. New York J Med, 49: 629, 1949
4. Scott, W. W. and Boyd, H. L.: Combined hormonal control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Urol, 101: 86, 1968
5. Soloway, M. S., Pareek, K., Sharifi, R., Wajsman, Z., McLeod, D., Wood, D. P., Jr. et al: Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol, 167: 112, 2002
6. Pilepich, M., Winter, K., Byhardt, R. W., Mesic, J. B., Machtay, M., Hanks, G. E. et al: Androgen ablation adjuvant to definitive radiotherapy in carcinoma of the prostate: year 2000 update of RTOG phase III studies 86-10 and 85-31. Presented at annual meeting of ASTRO, abstract 114, 2000
7. Hanks, G. E., Lu, J. D., Machtay, M., Venbatesan, V. M., Pinover, W. H., Byhardt, R. W. et al: RTOG protocol 92-02: a phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. J Rad Oncol Biol Phys, 48: 110, 2000
8. Ludgate, C. M., Lim, J. T., Wilson, A. G., Alexander, A. S. and Wilson, K. S.: Neoadjuvant hormone therapy and external beam radiation for localized prostate cancer: Vancouver Island Cancer Centre experience. Can J Urol, 7: 937, 2000
9. Pilepich, M. V., Krall, J. M., al-Sarraf, M., John, M. J., Doggett, R. L., Sause, W. T. et al: Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology, 45: 616, 1995
10. Gleave, M. E., La Bianca, S. E., Goldenberg, S. L., Jones, E. C., Bruchovsky, N. and Sullivan, L. D.: Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up. Urology, 56: 289, 2000
11. Cher, M. L., Shinohara, K., Breslin, S., Vapnek, J. and Carroll, P. R.: High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Br J Urol, 75: 771, 1995